- Report
- February 2024
- 175 Pages
Global
From €4636EUR$5,000USD£3,888GBP
- Report
- September 2024
- 164 Pages
Global
From €5054EUR$5,450USD£4,238GBP
- Report
- July 2024
- 142 Pages
Global
From €3615EUR$3,899USD£3,032GBP
- Report
- January 2024
- 200 Pages
Global
From €3848EUR$4,150USD£3,227GBP
- Report
- July 2024
- 121 Pages
North America
From €3430EUR$3,699USD£2,876GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1855EUR$2,000USD£1,555GBP
- Report
- July 2024
- 162 Pages
Africa
From €2318EUR$2,500USD£1,944GBP
- Report
- October 2023
- 186 Pages
Global
From €5100EUR$5,500USD£4,277GBP
- Report
- June 2024
- 182 Pages
Global
From €3653EUR$3,939USD£3,063GBP
- Report
- June 2024
- 185 Pages
Global
From €3653EUR$3,939USD£3,063GBP
- Report
- March 2024
- 194 Pages
Global
From €3653EUR$3,939USD£3,063GBP
- Report
- July 2024
- 288 Pages
Global
From €5369EUR$5,992USD£4,350GBP
- Report
- October 2023
- 75 Pages
Global
From €5517EUR$5,950USD£4,627GBP
- Report
- March 2024
- 195 Pages
Global
From €3653EUR$3,939USD£3,063GBP
- Report
- May 2024
- 134 Pages
Global
From €6026EUR$6,499USD£5,054GBP
- Report
- October 2023
- 185 Pages
Global
From €4544EUR$4,900USD£3,810GBP
- Report
- October 2023
- 190 Pages
Global
From €4544EUR$4,900USD£3,810GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1855EUR$2,000USD£1,555GBP
- Drug Pipelines
- April 2024
- 50 Pages
Global
From €1391EUR$1,500USD£1,166GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1159EUR$1,250USD£972GBP
The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more